Yifeng Pharmacy to cancel restricted shares, hold Q3 earnings briefing

Yifeng Pharmacy Chain announced it will repurchase and cancel 25,516 restricted shares as part of its 2022 restricted stock incentive plan. This action, approved by the board on September 30, 2025, is due to five incentive recipients departing, being demoted, or failing to meet performance targets. Their granted but unvested shares are therefore ineligible for unlocking. The cancellation process is expected to be completed by November 27, 2025, altering the company's share structure.

In a separate announcement, Yifeng Pharmacy Chain will host a third-quarter performance briefing on December 2, 2025, from 4:00 p.m. to 5:00 p.m. at the Shanghai Stock Exchange Roadshow Center. This interactive online event, following the release of the third-quarter report on October 30, 2025, will allow investors to discuss the company's financial and operational results with key management. These include chairman and president Gao Yi, independent director Wang Xiaoyan, vice president and CFO Wang Yonghui, and board secretary Fan Wei. Investors can submit questions in advance from November 25 to November 28, 2025.